Keyphrases
Vitrectomy
100%
Microplasmin
100%
Vitreomacular Traction
100%
Intravitreal Administration
100%
Posterior Vitreous Detachment
75%
Intravitreal
25%
Before Surgery
25%
Pars Plana Vitrectomy
25%
Exposure Time
25%
Retinal Detachment
12%
Ultrasound
12%
Fluorescein Angiography
12%
Retinal Surfaces
12%
Ophthalmic Examination
12%
After Surgery
12%
Intravitreal Injection
12%
Fundus Photography
12%
Maculopathy
12%
Clinical Trials
12%
High Incidence
12%
Vitreoschisis
12%
B-mode Ultrasound
12%
Humphrey Visual Field
12%
Increased Dose
12%
Pharmacologic
12%
Visual Electrophysiology
12%
Phase III Clinical Trial
12%
Dose Escalation
12%
Safety Concerns
12%
Discontinuous Layer
12%
Anomalous Posterior Vitreous Detachment
12%
Medicine and Dentistry
Vitrectomy
100%
Intravitreal Administration
100%
Ocriplasmin
100%
Posterior Vitreous Detachment
87%
Clinical Trial
25%
Pars Plana Vitrectomy
25%
Retinal Detachment
12%
Visual Field
12%
Fluorescein Angiography
12%
Fundus Photography
12%
B Scan
12%
Maculopathy
12%
Vitreous
12%
Echography
12%
Electrophysiology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Intravitreal Administration
100%
Ocriplasmin
100%
Vitreous Body Detachment
87%
Clinical Trial
25%
Retina Detachment
12%
Fluorescein
12%
Retina Maculopathy
12%